糖尿病足的治療_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 谷涌泉

首都醫科大學宣武醫院血管外科首都醫科大學血管外科學系（北京 100053）;

Corresponding?author：

谷涌泉, Email: 15901598209@163.com

Keywords：

DOI：

10.7507/1007-9424.20150238

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 谷涌泉. 糖尿病足的治療. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(8): 914-916. doi: 10.7507/1007-9424.20150238 Copy

1.	Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12):1090-1101.
2.	谷涌泉, 張建, 汪忠鎬.糖尿病下肢缺血外科治療方法的選擇.中國糖尿病雜志, 2007, 15(4):193-195.
3.	王愛紅, 趙湜, 李強, 等.中國部分省市糖尿病足調查及醫學經濟學分析.中華內分泌代謝雜志, 2005, 1(6):496-499.
4.	許樟榮, 敬華, 錢榮.糖尿病足國際臨床指南.北京:人民軍醫出版社, 2003:6-9.
5.	谷涌泉, 張建, 趙峰, 等.老年人糖尿病下肢動脈粥樣硬化臨床特點及相關因素的研究.中華老年多器官疾病雜志, 2007, 6(5):325-328.
6.	齊立行, 谷涌泉, 俞恒錫, 等.糖尿病性和非糖尿病性動脈硬化下肢血管造影特點比較及其臨床意義.中華糖尿病雜志, 2005, 13(6):412-413, 415.
7.	Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care, 1993, 16(8):1199-1209.
8.	谷涌泉, 張建, 俞恒錫, 等.下肢遠端動脈旁路移植治療糖尿病足46例報告.中國實用外科雜志, 2003, 23(8):487-489.
9.	羅濤, 谷涌泉, 俞恒錫, 等.復合血管序貫式旁路移植術治療慢性肢體缺血的臨床分析.中國普通外科雜志, 2007, 16(6):529-532.
10.	谷涌泉, 張建, 齊立行, 等.遠端動脈旁路移植附加動靜脈吻合治療嚴重下肢缺血21例.中華普通外科雜志, 2005, 20(9):578-580.
11.	Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006, 354(18):1879-1888.
12.	Laird JR, Katzen BT, Scheinert D, et al; RESILIENT Investigators. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication:three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther, 2012, 19(1):1-9.
13.	Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery:long-term results from the SIROCCO trial. J Endo-vasc Ther, 2006, 13(6):701-710.
14.	Dake MD, Scheinert D, Tepe G, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee:twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther, 2011, 18(5):613-623.
15.	Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease:twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv, 2011, 4(5):495-504.
16.	Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease:1-year results from the Achilles trial. J Am Coll Cardiol, 2012, 60(22):2290-2295.
17.	Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg, 2012, 55(2):390-398.
18.	Werner M, Schmidt A, Freyer M, et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia:long-term clinical and angiographic follow-up. J Endovasc Ther, 2012, 19(1):12-19.
19.	谷涌泉, 郭連瑞, 齊立行, 等.膝下動脈支架成形術治療嚴重下肢缺血.中華普通外科雜志, 2012, 27(3):184-186.
20.	谷涌泉, 張建, 齊立行, 等.小腿動脈球囊成形術治療2型糖尿病下肢缺血的療效觀察.中國糖尿病雜志, 2010, 18(2):132-134.
21.	Zeller T, Frank U, Bürgelin K, et al. Initial clinical experience with percutaneous atherectomy in the infragenicular arteries. J Endovasc Ther, 2003, 10(5):987-993.
22.	Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol, 2006, 48(8):1573-1578.
23.	McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia:use of percutaneous atherec-tomy in 579 lesions. Ann Surg, 2008, 248(4):519-527.
24.	谷涌泉, 郭連瑞, 齊立行, 等. SilverHawk斑塊切除治療動脈粥樣硬化導致的下肢缺血14例報告.中國微創外科雜志, 2011, 11(11):1022-1024.
25.	Yongquan G, Lianrui G, Lixing Q, et al. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter. Int Angiol, 2013, 32(4):362-367.
26.	Gu Y, Zhang J, Guo L, et al. A phaseⅠclinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia. J Gene Med, 2011, 13(11):602-610.
27.	郭連瑞, 谷涌泉, 張建, 等.自體骨髓干細胞移植治療糖尿病足13例報告.中華糖尿病雜志, 2004, 12(5):313-316.
28.	黃平平, 李尚珠, 韓明哲, 等.自體外周血干細胞移植治療下肢動脈硬化性閉塞癥.中華血液學雜志, 2003, 24(6):308-311.
29.	谷涌泉, 張建, 齊立行, 等.骨髓動員刺激后自體骨髓源單個核細胞移植治療下肢缺血的初步臨床研究.中國修復重建外科雜志, 2006, 8(10):1017-1020.
30.	谷涌泉, 張建, 齊立行, 等.自體骨髓干細胞移植治療下肢神經病變的效果:3例討論.中國臨床康復雜志, 2005, 9(18):46-48.

1. Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362(12):1090-1101.
2. 谷涌泉, 張建, 汪忠鎬.糖尿病下肢缺血外科治療方法的選擇.中國糖尿病雜志, 2007, 15(4):193-195.
3. 王愛紅, 趙湜, 李強, 等.中國部分省市糖尿病足調查及醫學經濟學分析.中華內分泌代謝雜志, 2005, 1(6):496-499.
4. 許樟榮, 敬華, 錢榮.糖尿病足國際臨床指南.北京:人民軍醫出版社, 2003:6-9.
5. 谷涌泉, 張建, 趙峰, 等.老年人糖尿病下肢動脈粥樣硬化臨床特點及相關因素的研究.中華老年多器官疾病雜志, 2007, 6(5):325-328.
6. 齊立行, 谷涌泉, 俞恒錫, 等.糖尿病性和非糖尿病性動脈硬化下肢血管造影特點比較及其臨床意義.中華糖尿病雜志, 2005, 13(6):412-413, 415.
7. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care, 1993, 16(8):1199-1209.
8. 谷涌泉, 張建, 俞恒錫, 等.下肢遠端動脈旁路移植治療糖尿病足46例報告.中國實用外科雜志, 2003, 23(8):487-489.
9. 羅濤, 谷涌泉, 俞恒錫, 等.復合血管序貫式旁路移植術治療慢性肢體缺血的臨床分析.中國普通外科雜志, 2007, 16(6):529-532.
10. 谷涌泉, 張建, 齊立行, 等.遠端動脈旁路移植附加動靜脈吻合治療嚴重下肢缺血21例.中華普通外科雜志, 2005, 20(9):578-580.
11. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006, 354(18):1879-1888.
12. Laird JR, Katzen BT, Scheinert D, et al; RESILIENT Investigators. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication:three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther, 2012, 19(1):1-9.
13. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery:long-term results from the SIROCCO trial. J Endo-vasc Ther, 2006, 13(6):701-710.
14. Dake MD, Scheinert D, Tepe G, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee:twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther, 2011, 18(5):613-623.
15. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease:twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv, 2011, 4(5):495-504.
16. Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease:1-year results from the Achilles trial. J Am Coll Cardiol, 2012, 60(22):2290-2295.
17. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg, 2012, 55(2):390-398.
18. Werner M, Schmidt A, Freyer M, et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia:long-term clinical and angiographic follow-up. J Endovasc Ther, 2012, 19(1):12-19.
19. 谷涌泉, 郭連瑞, 齊立行, 等.膝下動脈支架成形術治療嚴重下肢缺血.中華普通外科雜志, 2012, 27(3):184-186.
20. 谷涌泉, 張建, 齊立行, 等.小腿動脈球囊成形術治療2型糖尿病下肢缺血的療效觀察.中國糖尿病雜志, 2010, 18(2):132-134.
21. Zeller T, Frank U, Bürgelin K, et al. Initial clinical experience with percutaneous atherectomy in the infragenicular arteries. J Endovasc Ther, 2003, 10(5):987-993.
22. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol, 2006, 48(8):1573-1578.
23. McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia:use of percutaneous atherec-tomy in 579 lesions. Ann Surg, 2008, 248(4):519-527.
24. 谷涌泉, 郭連瑞, 齊立行, 等. SilverHawk斑塊切除治療動脈粥樣硬化導致的下肢缺血14例報告.中國微創外科雜志, 2011, 11(11):1022-1024.
25. Yongquan G, Lianrui G, Lixing Q, et al. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter. Int Angiol, 2013, 32(4):362-367.
26. Gu Y, Zhang J, Guo L, et al. A phaseⅠclinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia. J Gene Med, 2011, 13(11):602-610.
27. 郭連瑞, 谷涌泉, 張建, 等.自體骨髓干細胞移植治療糖尿病足13例報告.中華糖尿病雜志, 2004, 12(5):313-316.
28. 黃平平, 李尚珠, 韓明哲, 等.自體外周血干細胞移植治療下肢動脈硬化性閉塞癥.中華血液學雜志, 2003, 24(6):308-311.
29. 谷涌泉, 張建, 齊立行, 等.骨髓動員刺激后自體骨髓源單個核細胞移植治療下肢缺血的初步臨床研究.中國修復重建外科雜志, 2006, 8(10):1017-1020.
30. 谷涌泉, 張建, 齊立行, 等.自體骨髓干細胞移植治療下肢神經病變的效果:3例討論.中國臨床康復雜志, 2005, 9(18):46-48.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

糖尿病足的治療

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content